Source link : https://www.newshealth.biz/health-news/fda-warns-exosome-maker-for-marketing-outside-its-ind/
The FDA has warned Kimera Labs that it can’t sell its exosome product for uses outside of its recently secured investigational new drug (IND) application. In a warning letter that was posted to the FDA’s website last September, then removed, and then posted again this month, the agency also told the Miramar, Florida-based company that […]
Author : News Health
Publish date : 2024-01-22 17:34:58
Copyright for syndicated content belongs to the linked Source.